skip to search skip to navigation skip to main content

Archive: October 2015

Local Manufacturing Partnership launched in Iran

29th October 2015 in Local Manufacturing Launches

Tehran, Iran; 29 October 2015: The Ministry of Health and Medical Education in Iran has recently welcomed the three-way partnership agreement between itself, Astellas Pharma Middle East, North and Sub-Saharan Africa (MENA/SSA), and Behestan Group for the manufacturing of urology and transplantation pharmaceutical products. The existing manufacturing plant, owned by Behestan Tolid, will receive a…

Read Full Post

Ribomustin launched in Algeria

01st October 2015 in Product Launches

Algiers, Algeria, October 1, 2015: During the 12th annual meeting of the Algerian society of haematology and blood transfusion, Astellas Pharma Middle East, North and Sub-Saharan Africa (MENA/SSA) has introduced Bendamustine in Algeria for the treatment of Chronic Lymphocytic Leukaemia (CLL) and Indolent Non-Hodgkin’s Lymphoma (INHL). In 2012 the incidence of Non-Hodgkin’s Lymphoma (NHL) in…

Read Full Post

Privacy Policy  |  Terms of Use  |  Cookies PolicyCopyright © 2019 Astellas Pharma